Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hansch

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|May 1, 1986
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysisC D Selassie, Z X Fang, R L Li, et al.
Journal of Medicinal Chemistry|March 1, 1986
Thiopurine methyltransferase: structure-activity relationships for benzoic acid inhibitors and thiophenol substratesM M Ames, C D Selassie, L C Woodson, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|March 1, 1997
Correlation between hydrophobicity of short-chain aliphatic alcohols and their ability to alter plasma membrane integrityS C McKarns, C Hansch, W S Caldwell, et al.
Journal of Medicinal Chemistry|August 1, 1973
Structure-activity relationship of chloramphenicolsC Hansch, K Nakamoto, M Gorin, et al.
Advances in Neurology|January 1, 1982
Improved diagnostic yield in evaluation of multiple sclerosis using critical frequency of photic driving with pattern reversal-evoked potentialsS N Cohen, K Syndulko, E C Hansch, et al.
Cancer Chemotherapy Reports|March 1, 1975
Imidazole carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumorsV A Levin, D Crafts, C B Wilson, et al.
Radiology|January 22, 2000
Chronically occluded inferior venae cavae: endovascular treatmentM K Razavi, E C Hansch, S T Kee, et al.
The Journal of Biological Chemistry|March 10, 1982
Crystal structure of avian dihydrofolate reductase containing phenyltriazine and NADPHK W Volz, D A Matthews, R A Alden, et al.
Journal of Medicinal Chemistry|April 1, 1979
Quantitative structure-activity relationships in 1-aryl-2-(alkylamino)ethanol antimalarialsK H Kim, C Hansch, J Y Fukunaga, et al.
Journal of Medicinal Chemistry|June 1, 1978
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in miceG J Hatheway, C Hansch, K H Kim, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|May 1, 1986
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysisC D Selassie, Z X Fang, R L Li, et al.
Journal of Medicinal Chemistry|March 1, 1986
Thiopurine methyltransferase: structure-activity relationships for benzoic acid inhibitors and thiophenol substratesM M Ames, C D Selassie, L C Woodson, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|March 1, 1997
Correlation between hydrophobicity of short-chain aliphatic alcohols and their ability to alter plasma membrane integrityS C McKarns, C Hansch, W S Caldwell, et al.
Journal of Medicinal Chemistry|August 1, 1973
Structure-activity relationship of chloramphenicolsC Hansch, K Nakamoto, M Gorin, et al.
Advances in Neurology|January 1, 1982
Improved diagnostic yield in evaluation of multiple sclerosis using critical frequency of photic driving with pattern reversal-evoked potentialsS N Cohen, K Syndulko, E C Hansch, et al.
Cancer Chemotherapy Reports|March 1, 1975
Imidazole carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumorsV A Levin, D Crafts, C B Wilson, et al.
Radiology|January 22, 2000
Chronically occluded inferior venae cavae: endovascular treatmentM K Razavi, E C Hansch, S T Kee, et al.
The Journal of Biological Chemistry|March 10, 1982
Crystal structure of avian dihydrofolate reductase containing phenyltriazine and NADPHK W Volz, D A Matthews, R A Alden, et al.
Journal of Medicinal Chemistry|April 1, 1979
Quantitative structure-activity relationships in 1-aryl-2-(alkylamino)ethanol antimalarialsK H Kim, C Hansch, J Y Fukunaga, et al.
Journal of Medicinal Chemistry|June 1, 1978
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in miceG J Hatheway, C Hansch, K H Kim, et al.
Pageof 20